Foreward

While a multitude of novel, non-cytotoxic therapeutic alternatives continue to evolve, a significant number of patients still receive treatment that leads to severe neutropenia. In fact, the majority of hospitalized oncology patients are at least modestly neutropenic for part of their stay. The magnitude of the problem is real and managing patients with neutropenia is unique. The impact of neutropenia is felt on all disciplines: radiation oncology, surgical oncology and medical oncology, as well as by both physicians and nurses.
Source: Current Problems in Cancer - Category: Cancer & Oncology Authors: Source Type: research